Substantial numbers of clients with DSM-5® diagnoses will be treated with a combination of psychological and pharmacological treatments. Newer drugs are being introduced to treat mental disorders based on better understanding of the neurobiological contributions to mental disorders and the latest pharmacological research.
This seminar will update and increase your understanding of:
- The neurobiological underpinnings of major DSM-5® diagnoses
- The types and effects of drugs used to treat these diagnoses
- The responsibilities of the non-prescribing therapist to clients taking psychiatric medication
Specifics of the pharmacological treatment and drugs of choice for the DSM 5® Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will also be discussed. Unique to this seminar is information on the common types of psychotherapeutic drugs that client’s abuse (prescription drug abuse) and methods for prevention and early detection.
- Identify neurotransmitter systems and neuroanatomy underlying the biological basis.
- Describe the major classes of drugs used to treat mental disorders.
- Outline evidence-based guidelines for the use of specific medications for commonly occurring DSM-5® mental disorders.
- Compare and contrast the effects and side effects of antipsychotics, anti-depressants, benzodiazepines and other anxiolytics, anticonvulsants and drugs used to treat other mental disorders.
- Discuss the abuse liability of drugs used in the treatment of anxiety, insomnia, pain, and ADHD.
- Explain the role of clinicians with clients receiving psychotherapeutic medications as well as psychotherapy.
Behaviour and Psychotherapeutic Drug Actions
- Brain structures and circuits in behaviour
- Experience and regulate emotion
- Executive function and inhibitory control
- Reward systems
- Biogenic amines
- Excitatory neurotransmitters
- Endorphins and endocannabinoids
Your Role in Psychological and Pharmacological Combined Treatments
- Collaboration with prescribing professional
- Managing the combined treatments
- Referrals for medication
- Client psycho-education
- Monitoring drug effects and side-effects
- Adherence to combined treatments
Treatment of DSM-5® Mental Disorders
Schizophrenia Spectrum Disorders
- Biological theories of schizophrenia
- “Typical” antipsychotics for treatment
- Effects, side effects & cautions of high, medium, and low potency drugs
- “Atypical” antipsychotics for treatment schizophrenia
- Effects, side effects & cautions of atypicals
- Drugs for treatment-resistant schizophrenia
- Other uses of antipsychotic drugs
- Representative case discussion
- Neurobiology of depression
- Drugs used to treat depressive disorders & the effects, side effects & cautions
- Selective Serotonin Reuptake Inhibitors
- Serotonin-Norepinephrine Reuptake Inhibitors
- Atypical antidepressant agents
- Tricyclic antidepressants
- When a first-line antidepressant doesn’t work
- MAO Inhibitors
- Augmentation with antipsychotics
- What about herbs like St. John’s Wort?
- Representative case study
- Biological theories of DSM-5® Bipolar disorders
- Drugs used to treat bipolar disorders & the effects, side effects & cautions
- Combination antipsychotic-antidepressant drug Symbyax
Anxiety, Obsessive-Compulsive and Sleep-Wake Disorders
- The neurobiology of anxiety related disorders
- The structure of sleep
- Drugs used in treatment
- Benzodiazepine-like drugs
- Misuse of these drugs in treatment
- SSRI’s and other drugs used to treat anxiety
- Drugs used to treat OCD
ADHD and Neurocognitive Disorders
- Psychostimulants & the effects, side effects & cautions
- Antidepressants and Alpha-Adrenergic Agonists
- Major Neurocognitive Disorders
- Drugs used in the treatment of cognitive impairment and future treatments
Prescription Drug Abuse
- The risk of comorbid prescription drug abuse
- Classes of drugs that are frequently abused
- Prevention and early identification
- Case study
This is an individual version for private use only. (What is it?)
By adding this individual version in your basket you are agreeing that this DVD and any other Individual Version DVD purchased at Psychotherapydvds.com will be used for personal viewing only, and not for teaching, training, group viewing or any institutional use.
To buy Organisational Version of this training pack licensed for use with groups or at training events go to: Organisational Version of this product page
Alan S. Bloom, Ph.D., is professor of Pharmacology and Toxicology at the Medical College of Wisconsin where he teaches psychopharmacology to medical students and neuroscience graduate students. He earned a dual Ph.D. in psychology and pharmacology and consults regularly with psychiatrists and attorneys in drug abuse and other pharmacology related cases.
For the past 20 years, he has conducted research on the impact of drugs of abuse (marijuana, cocaine, etc.) on the brain through use of functional magnetic resonance imaging (fMRI). He directs research on the cognitive effects of chemotherapy drugs administered to women with breast cancer, commonly known as "chemo-brain". His studies have been funded by the NIH and other national organizations and reported in an extensive number of publications and presentations. Dr. Bloom has served on the NIDA Centres grant review panel and is an appointed member of the Controlled Substance Board of the State of Wisconsin. He is a strong and experienced presenter providing lively, information packed seminars.
Dr. Bloom encourages the active learning of participants through application of the material in case studies and problem-based learning. In 1997 he was elected to membership in the Medical College of Wisconsin Society of Teaching Scholars.
Dispatched from United Kingdom. International delivery available: Europe.
Individual Training Pack 8 CPD Hours – £153.00